GPCR-ome modulation upon ICP treatment

Scroll To Explore

“GPCR-ome” modulation upon PD1 / PDL1 axis blockade

 

co-authored with Explicyte, Bordeaux, France and Institut Bergonié, Bordeaux, France, this poster discloses an in-depth GPCR expression analysis from tumor microenvironment to dissect out mechanisms of resistance to immune checkpoint inhibitors. Such data open avenues for the discovery of the next generation of immune checkpoints.